drugs influencing cns psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing...
TRANSCRIPT
![Page 1: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/1.jpg)
![Page 2: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/2.jpg)
Drugs influencing CNSDrugs influencing CNS
• psychoterapeutic drugs (antipsychotics, psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs)antidepressants, mood-stabilzing drugs)
• anxiolytics, hypnoticsanxiolytics, hypnotics
• antiepilepticsantiepileptics
• local and general anestheticslocal and general anesthetics
• opioid analgesics and antagonistsopioid analgesics and antagonists
• drugs for neurodegenerative diseasesdrugs for neurodegenerative diseases
• drugs of abusedrugs of abuse
![Page 3: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/3.jpg)
Neurotransmitters – faciliate transmission of impulses
Norepinephrine (locus coeruleus – allertness, attention, consciousness; depression)
Acetylcholine (attention, learning, memory; demention, stimulate at Alzheimer´s disease)
Dopamine (motoric activity, reward system; Parkinson´s disease, depression, schizophrenia)
Serotonin (mood, anxiety, agressivity; Parkinson´s disease, schizophrenia)
GABA (inhibitory-Cl-; benzodiazepines; anxiolytic, sedative)
Glutamate (NMDA receptors; learning, memory, „cell death“ ,inhibit: Alzheimer´s disease)
Glycine (inhibitory-Cl-; the most common receptor in CNS)
Neuropeptides (enkephalins, VIP, subst.P, together with other neurotransmitters)
Endocanabioids (neuromodulatory lipids, memory, mood, analgesia...)
( NO nitric oxide) (neuronal NOS-1988; release of neurotransmitters)
![Page 4: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/4.jpg)
![Page 5: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/5.jpg)
Most psychotherapeutics influence processes on synapse
...influenceneurotransmitters
![Page 6: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/6.jpg)
Mood disorders = affective disorders
Unipolar disordersLarge depressive disorder
Dysthymia (chronic depression)
![Page 7: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/7.jpg)
Bipolar disorder
Cyklothymia (perzistent mood instability)
Type II (hypomania and depression)
Type I (alternation of mania and depression)
![Page 8: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/8.jpg)
Prevalence 5 – 6 %, men and women
One episode may last 4 – 6 months; risk of suicide 60×
Epizóda 1 2 3 4
![Page 9: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/9.jpg)
Provoking factorsBipolar mood disorder
![Page 10: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/10.jpg)
Non-pharmacologic Approaches to the Treatment of Depression(e.g. psychotherapy, electroconvulsive therapy, repetitive trancranial magnetic stimulation,if disturbances in biorhythms – light, sleep deprivation, ...)
![Page 11: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/11.jpg)
Therapy of Depression
mechanism of action of antidepressant drugs ÷ generally not fully understood ...
most antidepressants have effect on synthesis, release and degradation of neurotransmitters and their interaction with receptors
biogenic amine hypothesis (mood disorders result from abnormalities in serotonin, norepinephrine, or dopamine neurotransmission)
NOT VALID
![Page 12: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/12.jpg)
ANTIDEPRESSANTSdifferent divisions
CLASSICAL
TCA – tricyclic antidepressantsIMAO – inhibitors of MAO
NEWER
RIMASSRISNRISARINaSSANDRIothers
![Page 13: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/13.jpg)
Tricyclic antidepresants (TCA)
Chemical structure - 3 cycles (nomenclature)→ significantly lipophilic substances
developed from antihistaminics
Mechanism of action:Block reuptake of norepinephrine (NE) and serotonin (5-HT) Dopamine neurotranssion is less influenced
Most TCA block following receptors responsible for ADR:H1-receptors, -adrenoreceptors, muscarinic-receptors
also outside of CNS!
imipramín
![Page 14: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/14.jpg)
TCA
![Page 15: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/15.jpg)
TCA
imipramine dosulepine desimipramine quinupramine amitriptyline clomipramine nortriptyline propizepine
pharmacokinetics: p.o. administration, first pass effect, low variable bioavailability, strong binding to plasma proteins
metabolised in liver, active metabolites CYP450 polymorfism, interactions
![Page 16: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/16.jpg)
TCA
Adverse drug reaction
Muscarinic receptor blockade („atropine-like“, anticholinergic)
dry mouth, blurred vision – acomodation inability, obstipation, retention of urine, palpitations, tachycardia
-adrenergic receptor blockade (in older age) postural (orthostatic) hypotension + reflex tachycardia H1-receptor blockade (amitriptyline)
sedation, drowsiness, impaired concentration Sexual dysfunction, cardiac arrhythmias
![Page 17: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/17.jpg)
Monoamine oxidase inhibitors (IMAO)
Decrease degradation of monoamines
MAO is responsible for degradation of the biogenic amine neurotransmitters (norepinephrine, serotonin, dopamine)
tranylcypromine – nonspecific irreversible inhibitor of MAO; tyramine reaction
selegiline – treatment of Parkinson´s disease – inhibitor of MAO B (MAO B degrades DOP)
„increase activity“ – euphoria + excitation
![Page 18: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/18.jpg)
IMAO
tyramine reaction → combination with tyramine (indirect sympathomimetic) from food strongly increases responses to sympathicus stimuli
It is mainly manifested by hypertension crisis – strong headache, risk of cerebral bleeding
physiologically tyramine from food very quickly splits MAO, at pharmacological inhibition (irreversible) with MAO it isn´t possible
→ patients taking IMAO must avoid intake of tyramine
→ strict dietary regimen!!
main sources of tyramine in food: cheese, bier,
wine, yeast
![Page 19: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/19.jpg)
IMAO
ADRs:
postural hypotensionCNS stimulation: tremor, excitation, insomnia, spasmsincreased apetite
Tox.: hepatotoxicity
![Page 20: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/20.jpg)
RIMA - reversible inhibitors of MAO A
moclobemid –– MAO A degrades SER, DOP and NE
![Page 21: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/21.jpg)
Selective Serotonin Reuptake Inhibitors - SSRI
Indications: antidepressants anxiety disorders, OCD bulimia, gambling
FluoxetineFluvoxamineParoxetineSertalineCitalopramEscitalopram
pharmacokinetics: p.o. administrationPolymorfism of metab. in liver (2D6, 2C19)Long T1/2 (50 h)
Interactions – biding to plasma proteins: TCA, betablockers, benzodiazepines
![Page 22: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/22.jpg)
SSRI
ADRs --- better profile than TCA and IMAOGIT – nausea, vomitting, abdominal spasms, accelerated peristalsis,
diarrhea
HeadacheSexua dysfunctionAkathisiaInsomnia and fatigue Sometimes - increased anxiety / agitation at the beginning
of therapy
Serotonin syndrome at intoxications or interactions
![Page 23: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/23.jpg)
Serotonin syndrome Also after 1 dose of SSRI ! Symptoms – soon, till 6 hours
Neuromuscular: akathisia, tremor, hyperreflexia, myoclonus, hypertonicity
Change in mental status: agitation, delirium
Autonomic hyperactivity: tachycardia, midriasis, sweatting, increased motility of GIT,
hyperthermia
![Page 24: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/24.jpg)
Serotonin syndromeRISK – COMBINATION OF DRUGS
SSRI + inhibitors of CYP 450SSRI + serotoninergic AD (trazodone, clomipramine,
venlafaxine)SSRI + IMAOSSRI + lithiumSSRI + analgetics (tramadol, fentanyl, pentazocine), SSRI + antiemetics (metoclopramide), antimigraine drugs
(sumatriptan)SSRI + antibiotics (linezolid), others: ritonavir,
dextromethorphan, LSD....
![Page 25: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/25.jpg)
Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRI): venlafaxin
Selective Serotonin Norepinephrine ane Dopamine Reuptake Inhibitors (NDRI): bupropion
Selective Norepinephrine Reuptake Inhibitors (NaRI): reboxetine
Serotonin Antagonists and Reuptake Inhibitors(SARI): trazodone
Noradrenergic and Specific Serotonergic Antidepressant (NaSSA): mirtazapine (increases noradrenergic and serotonin transmission; influence on receptors:1,2, a 5HT1A ,5HT1B)
![Page 26: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/26.jpg)
![Page 27: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/27.jpg)
Agomelatine
• Receptors for melatonine (subtype – MT1 and MT2, nucleus suprachiasmaticus) and serotonin (5HT2C- frontal cortex, hipocampus) in CNS
• Efect similar to melatonine
• Resynchronises cirkadian rhythms
![Page 28: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/28.jpg)
Alprazolam
• benzodiazepine
• Anxiolytic effectt at generalized anxiety (neurosis) till 20 min.
• Depression – latency of effect 1-6 weeks
• Neuroprotective effect (unlike other benzodiazepines)
![Page 29: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/29.jpg)
Therapy of Bipolar Disorder – mood stabilizing drugs
Acute treatment - 2 months - manage mania ÷ depression
Stabilizing treatment - 6 months – prevention of recurrence
Prophylactic treatment- 12 months..... – long-term prophylaxy
Bipolar affective disorder
![Page 30: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/30.jpg)
A. Therapy of mania Goal: influence irritability, agitation, agressivity, impulsivity
Lithium
Selected antiepileptic drugs (valproic acid, carbamazepine, clonazepan, lamotrigine)
Atypical antipsychotics – olanzapine, risperidone, quetiapine, aripiprazole
Bipolar affective disorder
![Page 31: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/31.jpg)
B. Therapy of bipolar depression Goal: no depressive symptomatology
ATTENTION reoccurence of mania in (20-40%!)
Lithium
Antidepressants (TCA, SSRI)
Lamotrigine, quetiapine
Bipolar affective disorder
![Page 32: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/32.jpg)
Lithium
•In contrast to other antidepressants effective mainly in manic phase, used mainly as prophylaxis of bipolar depression
•Mechanism of action unclear:
-interference with Na+/K+ ATPase
-interference with cAMP formation
-interference with inositol phosphates formation
-numerous and complex effect on neurotransmitter systems
•Very small therapeutic range: 0,5-1,0 mmol/l
![Page 33: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/33.jpg)
Lithium
•Before treatment needed to exclude cardiopathia and nephropathia
•ADR:
- at the treatment beginning: GIT problems, tiredness, shaking of fingers of hand; dissapear in several weeks
- late: polydipsia, polyuria, hypothyreosis, increased weight, cardiopatia, forgetting, teratogenic effects
•Intoxication: tremor, twitching, apathia, muscle weekness, convulsions, coma
•Many drug onteractions – e.g. increased lithemia at simultaneous administration of diuretic and antirheumatic drugs
![Page 34: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/34.jpg)
Drug Induced Psychiatric Disorders
![Page 35: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/35.jpg)
Other Selected Drugs
![Page 36: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/36.jpg)
Antipsychotics (Neuroleptics)
Indications:
• Psychiatric– Psychoses – including delusions, hallucinations, disordered
thoughts (particularly in shizophrenia and bipolar disorder)– At conditions of acute patologic agressivity and agitation
(chlorpromazine, levopromazine, haloperidol)
• Nonpsychiatric– Antiemetic effect – already at low doses (e.g.
thiethylperazine – suppositories, injections)– Neuroleptanalgezie – droperidol + fentanyl
![Page 37: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/37.jpg)
Antipsychotics (Neuroleptics)
Contraindications:
intoxiction with substances depressing CNS, neuroleptic malignant syndrome history, Parkinson´s syndrome, be carefull at patients with kidney and liver problems
![Page 38: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/38.jpg)
Antipsychotics (Neuroleptics)
Mechanism of action:
All antipsychotic drugs tend to block D2 receptors in the dopamine pathways of the brain. This means that dopamine released in these pathways has less effect.
Excess release of dopamine in the mesolimbic pathway has been linked to psychotic experiences.
Typical antipsychotics are not particularly selective and also block dopamine receptors in the mesocortical pathway, tuberoinfundibular pathway, and the nigrostriatal pathway – ADR.
Atypical antipsychotic drugs have a similar blocking effect on D2 receptors. Some also block or partially block serotonin receptors (particularly 5HT2A, C and 5HT1A receptors) – can influence the "negative symptoms" of schizophrenia.
![Page 39: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/39.jpg)
Antipsychotics (Neuroleptics)
Antipsychotics
(classical) typical atypical (clozapine, risperidone)
basal incisive (chlorpromazine) (haloperidol)
![Page 40: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/40.jpg)
I. Typical (1st generation) neuroleptics
• a) basal (sedative): - chlorpromazine (model drug, phenothiazine structure)
- levomepromazine - chlorprothixene, thioridazine
• b) incisive: - haloperidol (model drug, butyrophenone structure)
- fluphenazine, flupenthixol, clopenthixol
![Page 41: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/41.jpg)
II. Atypical (2nd generation) neuroleptics
• „Multi Acting Receptor Targeted Antipsychotics“ (MARTA)– olanzapine, zotepine, quetiapine,– clozapine– Blokujú D1/2, α, H1, M a 5-HT2 receptory
• „Serotonin and Dopamin receptor antagonists“ (SDA)– risperidone, ziprasidone
• D2-selektívne antagonisty– sulpiride, amisulpiride
![Page 42: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/42.jpg)
Antipsychotics (Neuroleptics) - ADRs
blockade of dopamine receptors – extrapyramidal side effects, hyperprolactinaemia anticholinergic – sinus tachycardia, obstipation, retention of
urine, dry mucosas, mouth, disturbances of acomodations, increased intraoccular pressure, etc.
antiadrenergic – ortosthatic hypotension, impotence, etc. antihistaminic – sedation, weight gain, etc.Neuroleptic malignant syndrome
![Page 43: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/43.jpg)
Extrapyramidal ADRs ADRs type A
• D2 blockade in striatum
• more frequent after typical incisive neuroleptics
– Acute (reversible)• Parkinson´s syndrome: tremor, muscle rigidity,
hypokinesia/akinesia:• Acute dystonia – painful muscle spasms, till 24-96hours
– Orofacial muscles – e.g. blepharospasmus (eye lashes), oculogyric crisis – upward deviation of the eyes …
– Neck muscles (torticollis)– Protrusion of the tongue– Pharyngo-laryngeal muscles – life-threatening
• Akathisia – Interanl sence of motor restlessness („restless leg syndrome“) . Treatment: benzodiazepines, beta-blockers.
![Page 44: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/44.jpg)
Extrapyramidal ADRs ADRs type A
• Late (often irreversible) – Tardive dyskinesia
» Uncontrolled movements of face/tongue and limbs
» Development after months even years of treatment
» Bizarre movements of tongue, chewing, „rabbit lip syndrome“ – problems with speaking and eating, facial grimaces …
» Choreiform movements of limbs
» up-regulation of D-receptors in striatum?
![Page 45: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/45.jpg)
Neuroleptic Malignant SyndromeADR type B
– All neuroleptics – (potent D2-blockers probably more)
– Rare (incidence 0.07-0.2%)
– Potentially life-threatening condition (mortality cca 5-12%)
– Clinical symptoms
• severe muscle rigidity, hyperthermia (>38ºC), profuse sweating, tachycardia, tremor, altered mental functions
– Mechanism – excessive blockade of D2 in striatum and hypothalamus?
– Treatment
• Cooling of the body ! + antipyretics
• D2-agonists – bromocryptine, amantadine + D-precursors (L-DOPA)
• Dantrolen – blocks Ca2+ release – controversial
![Page 46: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/46.jpg)
Antipsychotics
classical (typical) atypical (↑ AP ef., ↓ EP ADR, ↓ other ADR)
basal incisive (↓ AP ef., ↓ EP ADR (↑ AP ef., ↑ EP ADR
↑ other ADR) ↓ other ADR)
![Page 47: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/47.jpg)
Benzodiazepines have hypnotic, anxiolytic, anticonvulsive, muscle relaxant, amnestic effects – difference according to the site to which they on receptor bind
!!! interaction with s alcohol!!!
antidote of benzodiazepines - specific antagonist FLUMAZENIL
![Page 48: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/48.jpg)
γ-AMINOBUTIRIC ACID
receptor of GABA-A opens or closes Cl- channels, alosterically modulated by benzodiazepine receptors, and also by nonbenzodiazepine hypnotics
GABA-B
binding of muscle relaxants (BACLOFEN)
subtype of receptor and its localisation:
1-benzodiazepine receptor – anxiolytic sedative effect, highest density in cerebellum
2-benzodiazepine receptor – myorelaxant effect, in striatum and spine
3-benzodiazepine receptor – in kidneys, unknown effect
![Page 49: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/49.jpg)
if the patient is too calm, he is loosing motivation
stress situation leading to anxiety is temporary and removable
Benzodiazepines(max. 4-6 weeks)
rebound phenomenon
![Page 50: Drugs influencing CNS psychoterapeutic drugs (antipsychotics, antidepressants, mood-stabilzing drugs) psychoterapeutic drugs (antipsychotics, antidepressants,](https://reader033.vdocuments.site/reader033/viewer/2022061517/56649dc75503460f94abcbcc/html5/thumbnails/50.jpg)
anticonvulsive and myorelaxant effect, rapid onset of effect of some benzodiazepines (after parenteral administration) →
→ therapy of emergency conditions! (status epilepticus, intoxications with spasms)
classically diazepam, recently promoted lorazepam (a lower risk of recurrence)